Evidence for the existence of these leukemia stemcells (LSCs) was first reported when a population of humanCD34+CD38− AML patient cells successfullyinitiated AML in a SCID mouse xenograft model4, 5, 6. This evidence concerns the gene CD38 and acute myeloid leukemia.